- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
Market Overview
The Cell and Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Cell and Gene Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Cell and Gene Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cell and Gene Therapy market has been segmented into:
Rare Diseases
Oncology
Hematology
Cardiovascular
Ophthalmology
Neurology
Other Therapeutic Classes
By Application, Cell and Gene Therapy has been segmented into:
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Hospital
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cell and Gene Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Cell and Gene Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cell and Gene Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Cell and Gene Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cell and Gene Therapy Market Share Analysis
Cell and Gene Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cell and Gene Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cell and Gene Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Cell and Gene Therapy are:
Amgen Inc.
Novartis AG
Fibrocell Science, Inc.
bluebird bio, Inc.
Kolon TissueGene, Inc.
Dendreon Pharmaceuticals LLC.
Organogenesis Holdings Inc.
Kite Pharma, Inc.
Human Stem Cells Institute
Orchard Therapeutics plc.
Spark Therapeutics, Inc.
Pfizer, Inc.
Vericel Corporation
Sibiono GeneTech Co. Ltd.,
RENOVA THERAPEUTICS
ViroMed Co., Ltd.
Shanghai Sunway Biotech Co., Ltd.,
Among other players domestic and global, Cell and Gene Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Cell and Gene Therapy Market Overview
1.1 Product Overview and Scope of Cell and Gene Therapy
1.2 Classification of Cell and Gene Therapy by Type
1.2.1 Global Cell and Gene Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cell and Gene Therapy Revenue Market Share by Type in 2019
1.2.3 Rare Diseases
1.2.4 Oncology
1.2.5 Hematology
1.2.6 Cardiovascular
1.2.7 Ophthalmology
1.2.8 Neurology
1.2.9 Other Therapeutic Classes
1.3 Global Cell and Gene Therapy Market by Application
1.3.1 Overview: Global Cell and Gene Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Contract Research Organizations (CROs)
1.3.5 Hospital
1.3.6 Others
1.4 Global Cell and Gene Therapy Market by Regions
1.4.1 Global Cell and Gene Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cell and Gene Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cell and Gene Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cell and Gene Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cell and Gene Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cell and Gene Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cell and Gene Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Amgen Inc.
2.1.1 Amgen Inc. Details
2.1.2 Amgen Inc. Major Business
2.1.3 Amgen Inc. SWOT Analysis
2.1.4 Amgen Inc. Product and Services
2.1.5 Amgen Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business
2.2.3 Novartis AG SWOT Analysis
2.2.4 Novartis AG Product and Services
2.2.5 Novartis AG Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Fibrocell Science, Inc.
2.3.1 Fibrocell Science, Inc. Details
2.3.2 Fibrocell Science, Inc. Major Business
2.3.3 Fibrocell Science, Inc. SWOT Analysis
2.3.4 Fibrocell Science, Inc. Product and Services
2.3.5 Fibrocell Science, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 bluebird bio, Inc.
2.4.1 bluebird bio, Inc. Details
2.4.2 bluebird bio, Inc. Major Business
2.4.3 bluebird bio, Inc. SWOT Analysis
2.4.4 bluebird bio, Inc. Product and Services
2.4.5 bluebird bio, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kolon TissueGene, Inc.
2.5.1 Kolon TissueGene, Inc. Details
2.5.2 Kolon TissueGene, Inc. Major Business
2.5.3 Kolon TissueGene, Inc. SWOT Analysis
2.5.4 Kolon TissueGene, Inc. Product and Services
2.5.5 Kolon TissueGene, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Dendreon Pharmaceuticals LLC.
2.6.1 Dendreon Pharmaceuticals LLC. Details
2.6.2 Dendreon Pharmaceuticals LLC. Major Business
2.6.3 Dendreon Pharmaceuticals LLC. Product and Services
2.6.4 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 Organogenesis Holdings Inc.
2.7.1 Organogenesis Holdings Inc. Details
2.7.2 Organogenesis Holdings Inc. Major Business
2.7.3 Organogenesis Holdings Inc. Product and Services
2.7.4 Organogenesis Holdings Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Kite Pharma, Inc.
2.8.1 Kite Pharma, Inc. Details
2.8.2 Kite Pharma, Inc. Major Business
2.8.3 Kite Pharma, Inc. Product and Services
2.8.4 Kite Pharma, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Human Stem Cells Institute
2.9.1 Human Stem Cells Institute Details
2.9.2 Human Stem Cells Institute Major Business
2.9.3 Human Stem Cells Institute Product and Services
2.9.4 Human Stem Cells Institute Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Orchard Therapeutics plc.
2.10.1 Orchard Therapeutics plc. Details
2.10.2 Orchard Therapeutics plc. Major Business
2.10.3 Orchard Therapeutics plc. Product and Services
2.10.4 Orchard Therapeutics plc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.11 Spark Therapeutics, Inc.
2.11.1 Spark Therapeutics, Inc. Details
2.11.2 Spark Therapeutics, Inc. Major Business
2.11.3 Spark Therapeutics, Inc. Product and Services
2.11.4 Spark Therapeutics, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.12 Pfizer, Inc.
2.12.1 Pfizer, Inc. Details
2.12.2 Pfizer, Inc. Major Business
2.12.3 Pfizer, Inc. Product and Services
2.12.4 Pfizer, Inc. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.13 Vericel Corporation
2.13.1 Vericel Corporation Details
2.13.2 Vericel Corporation Major Business
2.13.3 Vericel Corporation Product and Services
2.13.4 Vericel Corporation Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.14 Sibiono GeneTech Co. Ltd.,
2.14.1 Sibiono GeneTech Co. Ltd., Details
2.14.2 Sibiono GeneTech Co. Ltd., Major Business
2.14.3 Sibiono GeneTech Co. Ltd., Product and Services
2.14.4 Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.15 RENOVA THERAPEUTICS
2.15.1 RENOVA THERAPEUTICS Details
2.15.2 RENOVA THERAPEUTICS Major Business
2.15.3 RENOVA THERAPEUTICS Product and Services
2.15.4 RENOVA THERAPEUTICS Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.16 ViroMed Co., Ltd.
2.16.1 ViroMed Co., Ltd. Details
2.16.2 ViroMed Co., Ltd. Major Business
2.16.3 ViroMed Co., Ltd. Product and Services
2.16.4 ViroMed Co., Ltd. Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.17 Shanghai Sunway Biotech Co., Ltd.,
2.17.1 Shanghai Sunway Biotech Co., Ltd., Details
2.17.2 Shanghai Sunway Biotech Co., Ltd., Major Business
2.17.3 Shanghai Sunway Biotech Co., Ltd., Product and Services
2.17.4 Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Cell and Gene Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cell and Gene Therapy Players Market Share
3.2.2 Top 10 Cell and Gene Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cell and Gene Therapy Revenue and Market Share by Regions
4.2 North America Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
5 North America Cell and Gene Therapy Revenue by Countries
5.1 North America Cell and Gene Therapy Revenue by Countries (2015-2020)
5.2 USA Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
6 Europe Cell and Gene Therapy Revenue by Countries
6.1 Europe Cell and Gene Therapy Revenue by Countries (2015-2020)
6.2 Germany Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
6.4 France Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cell and Gene Therapy Revenue by Countries
7.1 Asia-Pacific Cell and Gene Therapy Revenue by Countries (2015-2020)
7.2 China Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
7.5 India Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
8 South America Cell and Gene Therapy Revenue by Countries
8.1 South America Cell and Gene Therapy Revenue by Countries (2015-2020)
8.2 Brazil Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cell and Gene Therapy by Countries
9.1 Middle East & Africa Cell and Gene Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cell and Gene Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Cell and Gene Therapy Market Forecast by Type (2019-2024)
10.3 Rare Diseases Revenue Growth Rate (2015-2025)
10.4 Oncology Revenue Growth Rate (2015-2025)
10.5 Hematology Revenue Growth Rate (2015-2025)
10.6 Cardiovascular Revenue Growth Rate (2015-2025)
10.7 Ophthalmology Revenue Growth Rate (2015-2025)
10.8 Neurology Revenue Growth Rate (2015-2025)
10.9 Other Therapeutic Classes Revenue Growth Rate (2015-2025)
11 Global Cell and Gene Therapy Market Segment by Application
11.1 Global Cell and Gene Therapy Revenue Market Share by Application (2015-2020)
11.2 Cell and Gene Therapy Market Forecast by Application (2019-2024)
11.3 Pharmaceutical and Biotechnology Companies Revenue Growth (2015-2020)
11.4 Research and Academic Institutions Revenue Growth (2015-2020)
11.5 Contract Research Organizations (CROs) Revenue Growth (2015-2020)
11.6 Hospital Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Cell and Gene Therapy Market Size Forecast (2021-2025)
12.1 Global Cell and Gene Therapy Market Size Forecast (2021-2025)
12.2 Global Cell and Gene Therapy Market Forecast by Regions (2021-2025)
12.3 North America Cell and Gene Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Cell and Gene Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cell and Gene Therapy Revenue Market Forecast (2021-2025)
12.6 South America Cell and Gene Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cell and Gene Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Cell and Gene Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cell and Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cell and Gene Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cell and Gene Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Cell and Gene Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Amgen Inc. Corporate Information, Location and Competitors
Table 7. Amgen Inc. Cell and Gene Therapy Major Business
Table 8. Amgen Inc. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Amgen Inc. SWOT Analysis
Table 10. Amgen Inc. Cell and Gene Therapy Product and Solutions
Table 11. Amgen Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Novartis AG Corporate Information, Location and Competitors
Table 13. Novartis AG Cell and Gene Therapy Major Business
Table 14. Novartis AG Cell and Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Novartis AG SWOT Analysis
Table 16. Novartis AG Cell and Gene Therapy Product and Solutions
Table 17. Novartis AG Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Fibrocell Science, Inc. Corporate Information, Location and Competitors
Table 19. Fibrocell Science, Inc. Cell and Gene Therapy Major Business
Table 20. Fibrocell Science, Inc. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 21. Fibrocell Science, Inc. SWOT Analysis
Table 22. Fibrocell Science, Inc. Cell and Gene Therapy Product and Solutions
Table 23. Fibrocell Science, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. bluebird bio, Inc. Corporate Information, Location and Competitors
Table 25. bluebird bio, Inc. Cell and Gene Therapy Major Business
Table 26. bluebird bio, Inc. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 27. bluebird bio, Inc. SWOT Analysis
Table 28. bluebird bio, Inc. Cell and Gene Therapy Product and Solutions
Table 29. bluebird bio, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Kolon TissueGene, Inc. Corporate Information, Location and Competitors
Table 31. Kolon TissueGene, Inc. Cell and Gene Therapy Major Business
Table 32. Kolon TissueGene, Inc. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Kolon TissueGene, Inc. SWOT Analysis
Table 34. Kolon TissueGene, Inc. Cell and Gene Therapy Product and Solutions
Table 35. Kolon TissueGene, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Dendreon Pharmaceuticals LLC. Corporate Information, Location and Competitors
Table 37. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Major Business
Table 38. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Dendreon Pharmaceuticals LLC. SWOT Analysis
Table 40. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product and Solutions
Table 41. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Organogenesis Holdings Inc. Corporate Information, Location and Competitors
Table 43. Organogenesis Holdings Inc. Cell and Gene Therapy Major Business
Table 44. Organogenesis Holdings Inc. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 45. Organogenesis Holdings Inc. SWOT Analysis
Table 46. Organogenesis Holdings Inc. Cell and Gene Therapy Product and Solutions
Table 47. Organogenesis Holdings Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Kite Pharma, Inc. Corporate Information, Location and Competitors
Table 49. Kite Pharma, Inc. Cell and Gene Therapy Major Business
Table 50. Kite Pharma, Inc. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 51. Kite Pharma, Inc. SWOT Analysis
Table 52. Kite Pharma, Inc. Cell and Gene Therapy Product and Solutions
Table 53. Kite Pharma, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Human Stem Cells Institute Corporate Information, Location and Competitors
Table 55. Human Stem Cells Institute Cell and Gene Therapy Major Business
Table 56. Human Stem Cells Institute Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 57. Human Stem Cells Institute SWOT Analysis
Table 58. Human Stem Cells Institute Cell and Gene Therapy Product and Solutions
Table 59. Human Stem Cells Institute Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Orchard Therapeutics plc. Corporate Information, Location and Competitors
Table 61. Orchard Therapeutics plc. Cell and Gene Therapy Major Business
Table 62. Orchard Therapeutics plc. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 63. Orchard Therapeutics plc. SWOT Analysis
Table 64. Orchard Therapeutics plc. Cell and Gene Therapy Product and Solutions
Table 65. Orchard Therapeutics plc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Spark Therapeutics, Inc. Corporate Information, Location and Competitors
Table 67. Spark Therapeutics, Inc. Cell and Gene Therapy Major Business
Table 68. Spark Therapeutics, Inc. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 69. Spark Therapeutics, Inc. SWOT Analysis
Table 70. Spark Therapeutics, Inc. Cell and Gene Therapy Product and Solutions
Table 71. Spark Therapeutics, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Pfizer, Inc. Corporate Information, Location and Competitors
Table 73. Pfizer, Inc. Cell and Gene Therapy Major Business
Table 74. Pfizer, Inc. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 75. Pfizer, Inc. SWOT Analysis
Table 76. Pfizer, Inc. Cell and Gene Therapy Product and Solutions
Table 77. Pfizer, Inc. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Vericel Corporation Corporate Information, Location and Competitors
Table 79. Vericel Corporation Cell and Gene Therapy Major Business
Table 80. Vericel Corporation Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 81. Vericel Corporation SWOT Analysis
Table 82. Vericel Corporation Cell and Gene Therapy Product and Solutions
Table 83. Vericel Corporation Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. Sibiono GeneTech Co. Ltd., Corporate Information, Location and Competitors
Table 85. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Major Business
Table 86. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 87. Sibiono GeneTech Co. Ltd., SWOT Analysis
Table 88. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Product and Solutions
Table 89. Sibiono GeneTech Co. Ltd., Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. RENOVA THERAPEUTICS Corporate Information, Location and Competitors
Table 91. RENOVA THERAPEUTICS Cell and Gene Therapy Major Business
Table 92. RENOVA THERAPEUTICS Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 93. RENOVA THERAPEUTICS SWOT Analysis
Table 94. RENOVA THERAPEUTICS Cell and Gene Therapy Product and Solutions
Table 95. RENOVA THERAPEUTICS Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. ViroMed Co., Ltd. Corporate Information, Location and Competitors
Table 97. ViroMed Co., Ltd. Cell and Gene Therapy Major Business
Table 98. ViroMed Co., Ltd. Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 99. ViroMed Co., Ltd. SWOT Analysis
Table 100. ViroMed Co., Ltd. Cell and Gene Therapy Product and Solutions
Table 101. ViroMed Co., Ltd. Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Shanghai Sunway Biotech Co., Ltd., Corporate Information, Location and Competitors
Table 103. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Major Business
Table 104. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Total Revenue (USD Million) (2017-2018)
Table 105. Shanghai Sunway Biotech Co., Ltd., SWOT Analysis
Table 106. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Product and Solutions
Table 107. Shanghai Sunway Biotech Co., Ltd., Cell and Gene Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. Global Cell and Gene Therapy Revenue (Million USD) by Players (2015-2020)
Table 109. Global Cell and Gene Therapy Revenue Share by Players (2015-2020)
Table 110. Global Cell and Gene Therapy Revenue (Million USD) by Regions (2015-2020)
Table 111. Global Cell and Gene Therapy Revenue Market Share by Regions (2015-2020)
Table 112. North America Cell and Gene Therapy Revenue by Countries (2015-2020)
Table 113. North America Cell and Gene Therapy Revenue Market Share by Countries (2015-2020)
Table 114. Europe Cell and Gene Therapy Revenue (Million USD) by Countries (2015-2020)
Table 115. Asia-Pacific Cell and Gene Therapy Revenue (Million USD) by Countries (2015-2020)
Table 116. South America Cell and Gene Therapy Revenue by Countries (2015-2020)
Table 117. South America Cell and Gene Therapy Revenue Market Share by Countries (2015-2020)
Table 118. Middle East and Africa Cell and Gene Therapy Revenue (Million USD) by Countries (2015-2020)
Table 119. Middle East and Africa Cell and Gene Therapy Revenue Market Share by Countries (2015-2020)
Table 120. Global Cell and Gene Therapy Revenue (Million USD) by Type (2015-2020)
Table 121. Global Cell and Gene Therapy Revenue Share by Type (2015-2020)
Table 122. Global Cell and Gene Therapy Revenue Forecast by Type (2021-2025)
Table 123. Global Cell and Gene Therapy Revenue by Application (2015-2020)
Table 124. Global Cell and Gene Therapy Revenue Share by Application (2015-2020)
Table 125. Global Cell and Gene Therapy Revenue Forecast by Application (2021-2025)
Table 126. Global Cell and Gene Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cell and Gene Therapy Picture
Figure 2. Global Cell and Gene Therapy Revenue Market Share by Type in 2019
Figure 3. Rare Diseases Picture
Figure 4. Oncology Picture
Figure 5. Hematology Picture
Figure 6. Cardiovascular Picture
Figure 7. Ophthalmology Picture
Figure 8. Neurology Picture
Figure 9. Other Therapeutic Classes Picture
Figure 10. Cell and Gene Therapy Revenue Market Share by Application in 2019
Figure 11. Pharmaceutical and Biotechnology Companies Picture
Figure 12. Research and Academic Institutions Picture
Figure 13. Contract Research Organizations (CROs) Picture
Figure 14. Hospital Picture
Figure 15. Others Picture
Figure 16. Global Cell and Gene Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Cell and Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Cell and Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Cell and Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Cell and Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Cell and Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Cell and Gene Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Cell and Gene Therapy Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Cell and Gene Therapy Revenue Market Share in 2019
Figure 25. Global Top 10 Players Cell and Gene Therapy Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Cell and Gene Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Cell and Gene Therapy Revenue Market Share by Regions (2015-2020)
Figure 29. Global Cell and Gene Therapy Revenue Market Share by Regions in 2018
Figure 30. North America Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 31. Europe Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 33. South America Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 35. North America Cell and Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 36. North America Cell and Gene Therapy Revenue Market Share by Countries in 2019
Figure 37. USA Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 38. Canada Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Europe Cell and Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Cell and Gene Therapy Revenue Market Share by Countries in 2019
Figure 42. Germany Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 43. UK Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 44. France Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Russia Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Italy Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Cell and Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Cell and Gene Therapy Revenue Market Share by Countries in 2019
Figure 49. China Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 50. Japan Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Korea Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 52. India Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 54. South America Cell and Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 55. South America Cell and Gene Therapy Revenue Market Share by Countries in 2019
Figure 56. Brazil Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Cell and Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Cell and Gene Therapy Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 61. UAE Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Cell and Gene Therapy Revenue and Growth Rate (2015-2020)
Figure 64. Global Cell and Gene Therapy Revenue Share by Type (2015-2020)
Figure 65. Global Cell and Gene Therapy Revenue Share by Type in 2019
Figure 66. Global Cell and Gene Therapy Market Share Forecast by Type (2021-2025)
Figure 67. Global Rare Diseases Revenue Growth Rate (2015-2020)
Figure 68. Global Oncology Revenue Growth Rate (2015-2020)
Figure 69. Global Hematology Revenue Growth Rate (2015-2020)
Figure 70. Global Cardiovascular Revenue Growth Rate (2015-2020)
Figure 71. Global Ophthalmology Revenue Growth Rate (2015-2020)
Figure 72. Global Neurology Revenue Growth Rate (2015-2020)
Figure 73. Global Other Therapeutic Classes Revenue Growth Rate (2015-2020)
Figure 74. Global Cell and Gene Therapy Revenue Share by Application (2015-2020)
Figure 75. Global Cell and Gene Therapy Revenue Share by Application in 2019
Figure 76. Global Cell and Gene Therapy Market Share Forecast by Application (2021-2025)
Figure 77. Global Pharmaceutical and Biotechnology Companies Revenue Growth Rate (2015-2020)
Figure 78. Global Research and Academic Institutions Revenue Growth Rate (2015-2020)
Figure 79. Global Contract Research Organizations (CROs) Revenue Growth Rate (2015-2020)
Figure 80. Global Hospital Revenue Growth Rate (2015-2020)
Figure 81. Global Others Revenue Growth Rate (2015-2020)
Figure 82. Global Cell and Gene Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Cell and Gene Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Cell and Gene Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Cell and Gene Therapy Revenue Market Forecast (2021-2025)
Figure 86. Europe Cell and Gene Therapy Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Cell and Gene Therapy Revenue Market Forecast (2021-2025)
Figure 88. South America Cell and Gene Therapy Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Cell and Gene Therapy Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
Please feel free to write an email to us or to use our electronic ticketing system.
